2024 voluntary scheme for branded medicines pricing, access and growth
Why linked: NHS medicines pricing and access policy involving DHSC, NHS England, and industry; affects NHS funding and pharmaceutical sustainability
An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.